Table 2.
Barlow (n = 27) | FED (n = 32) | Control (n = 18) | |
---|---|---|---|
Annular parameters | |||
Antero-posterior diameter (mm) | 37.3 ± 6a,b | 34.4 ± 3.4b | 30.9 ± 3.5 |
Transverse diameter (mm) | 46.6 ± 5.0a,b | 43 ± 4.1b | 37.7 ± 4.0 |
3D mitral annular area (cm2) | 15 ± 2.8a,b | 13.3 ± 2.4b | 10.6 ± 2.3 |
Ellipticity index (%) | 126 ± 13 | 125 ± 10 | 117 ± 29 |
Non-planar angle of leaflets (°) | 151.6 ± 16.4a,b | 151.7 ± 12.7b | 147.2 ± 12.4 |
Annular height (mm) | 4.2 ± 1.5 | 3.7 ± 1.4 | 4.0 ± 1.0 |
AHCWR | 13.1 ± 4.1b | 13.9 ± 5.6 | 15.7 ± 3.7 |
Valvular parameters | |||
3D total leaflet area (cm2) | 18.5 ± 4.9a,b | 14.3 ± 2.9b | 11.3 ± 2.7 |
Prolapse height (mm) | 7.5 ± 2.8a,b | 5.8 ± 2.6b | 0.8 ± 0.6 |
Prolapse volume (ml) | 3.8 ± 2.9a,b | 1.2 ± 1.3b | 0.0 ± 0.1 |
Data are based on measurements on an end-systolic frame. Values are presented as mean ± SD
aindicates significant difference between the Barlow and FED groups
bindicates significant difference compared to control